Speakers

Anna Kulesza

Pharmaceutical Development and Regulatory Affairs Director

RegulaNova

Brett Vaughn

Radiopharmacist

Weill Cornell - Cornell University

Daniel Saragnese

Head of Manufacturing

Earli Inc.

Diane Abou

Assistant Professor at Washington University in ST. Louis and Lead Chemist at Curium

Washington University School of Medicine

Eric Burak

Chief Technical Officer

Fusion Pharmaceuticals

Geoffrey Johnson

Chair, Nuclear Medicine

Mayo Clinic

Giuseppe Carlucci

Assistant Professor

University of California Los Angeles

Izabela Tworowska

Chief Technology Officer BOD

Radiomedix Inc

Jarrod Longcor

Chief Operating Officer

Cellectar Biosciences Inc.

Kemp Dolliver

Director of Research and Senior Analyst

Brookline Capital Markets

Kevin Haehl

Chief Development Officer

Nucleus Radiopharma

Kevin Roland

Vice-President Radiopharmaceuticals Manufacturing

Fusion Pharmaceuticals

Michael Nickels

Associate professor

Washington University School of Medicine

Roland Turck

Managing Partner

TurckBio

Roy Brown

Vice President - Government Affairs and Strategic Alliances

Curium

Shaemus Gleason

Executive Vice President

Clarity Pharmaceuticals

Shankar Vallabhajosula

Scientific Advisor

Convergent Therapeutics

Thomas Birger Edén-Jensen

Head of Product Supply Operations

Bayer

Vishnu Dwadasi

Director - Manufacturing

Ashvattha Therapeutics

Ying Cai

Director - Supply Chain